Glofitamab
ML45833
Phase 2 small_molecule active
Quick answer
Glofitamab for MCL is a Phase 2 program (small_molecule) at Peking University Third Hospital with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Peking University Third Hospital
- Indication
- MCL
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active